Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
iBio, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC valued at 5.5% of the gross proceeds (effective 2023-12-05).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC
- Value
- 5.5% of the gross proceeds
- Effective
- 2023-12-05
Exact text from the filing
On December 5, 2023, the Company entered into a placement agency agreement (the “ Placement Agency Agreement ”) with A.G.P./Alliance Global Partners (“ A.G.P. ”), as lead placement agent, and Brookline Capital Markets, a division of Arcadia Securities, LLC (“ Brookline ”), as co-placement agent (A.G.P. and Brookline are referred to herein, collectively, as the “ Placement Agents ”), pursuant to which the Placement Agents agreed to serve as the placement agents for the Company on a “reasonable efforts basis” for the issuance and sale of the Shares and Warrants.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
iBio, Inc. entered into Purchase Agreement with certain purchaser (the "Purchasers") valued at approximately $3.6 million (effective 2023-12-05).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain purchaser (the "Purchasers")
- Value
- approximately $3.6 million
- Effective
- 2023-12-05
Exact text from the filing
On December 5, 2023, iBio, Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement with certain purchaser (the “ Purchasers ”) identified on the signature pages thereto (the “ Purchase Agreement ”), pursuant to which the Company agreed to issue and sell, in a public offering (the “ Offering ”), (i) 600,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), (ii) 1,650,000 pre-funded warrants
View on SEC.gov